CRI's new website that seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
This June, help us raise awareness of cancer immunotherapy as a revolutionary new treatment for patients today.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
Numerous challenges can derail progress in finding new immune-based cancer treatments. We're solving some of the biggest challenges, keeping promising new immunotherapies on the fast track to patients.
Get the latest updates on the field of cancer immunotherapy from CRI, including scientific breakthroughs, news stories, and program announcements.
When the Cancer Research Institute was founded in 1953, we knew then that immune-based treatments would transform cancer medicine. In more than six decades since, we've made numerous groundbreaking discoveries that have given more patients new hope today.
CRI programs have been instrumental in pioneering the field and funding discoveries, offering hope for the ultimate prevention and treatment of cancer using our immune system.
Watch interviews with our scientists to learn more about their groundbreaking research and its impact on patients, roundtable discussions from experts at CRI conferences and meetings, as well as public service announcements highlighting CRI's role in the field of cancer immunotherapy.
When Sharon Belvin learned that she had advanced melanoma at 22 years old, she enrolled in a CRI-funded clinical trial for a new antibody therapy called anti-CTLA-4. Today, the mother of two is still cancer free. Read more about her story and other cancer survivors who used these powerful new treatments called immunotherapies.
Stay up-to-date with the latest cancer immunotherapy news from CRI by signing up for our e-newsletter or alerts.